Details for New Drug Application (NDA): 019356
✉ Email this page to a colleague
The generic ingredient in NAFTIN is naftifine hydrochloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.
Summary for 019356
Tradename: | NAFTIN |
Applicant: | Sebela Ireland Ltd |
Ingredient: | naftifine hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 019356
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356 | NDA | Sebela Pharmaceuticals Inc. | 54766-770 | 54766-770-40 | 1 TUBE in 1 CARTON (54766-770-40) / 40 g in 1 TUBE |
NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356 | NDA | Sebela Pharmaceuticals Inc. | 54766-770 | 54766-770-60 | 1 TUBE in 1 CARTON (54766-770-60) / 60 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 1% | ||||
Approval Date: | Jun 18, 1990 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019356
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription